General Practitioners' Knowledge on Childhood Developmental and Behavioural Disorders

Singapore Medical Journal

Volumn 44, Issue 8, 2003, Pages 397-403

  Lian, Wee Bin ^a   Ho, S K Y ^a   Yeo, C L ^a   Ho, L Y ^a  

^a NONE

Author keywords

Behavioural; Childhood; Developmental; Knowledge; Special needs

Indexed keywords

ADULT; ARTICLE; BEHAVIOR DISORDER; CHILD DEVELOPMENT; CONTINUING EDUCATION; CURRICULUM; DEVELOPMENTAL DISORDER; FEMALE; GENERAL PRACTITIONER; HUMAN; MALE; MEDICAL EDUCATION; NORMAL HUMAN; PATIENT REFERRAL; PILOT STUDY; SINGAPORE;

ADULT; CHILD; CHILD BEHAVIOR DISORDERS; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; EDUCATION, MEDICAL, CONTINUING; FAMILY PRACTICE; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PILOT PROJECTS; POPULATION SURVEILLANCE; SINGAPORE;

EID: 0242268415     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Singapore Medical Council, February 2003.
2. Kanner L. Autistic disturbances of affective contact. Nervous Child 1943; 2:217-50.
3. Wing L, Gould J. Severe impairments of social interaction and associated abnormalities in children: epidermiology and classification. J Autism Dev Disord 1979; 9:11-30.
4. Nicholl A, Elliman D, Ross E. MMR vaccination and autism. BMJ 1998; 316:715-6.
5. Gilberg C, Heijbel H. MMR and Autism. Autism 1998; 2:423-4.
6. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. No evidence for measles, mumps, and rubella-vaccine associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998; 351:1327-8.
7. Taylor B, Millier E, Farrington CP, Petropoulos MC, Favat-Mayaud I, Li J, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. The Lancet 1999; 353:2026-9.
8. Kaye J, Mclero-Montes MM, Jick H. Mumps, measles and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001; 322(7284):460-3.
9. Kreesten MM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, et al. A population-based study on the measles, mumps, and rubella vaccination and autism. NEJM 2002; 19:1477-82.
10. Chez MG, Buchanan CP, Bagan BT, Hammer MS, McCarthy KS, Ovrutskaya I, et al. Secretin and autism: a two-part clinical investigation. J Autism Dev Disord 2000; 30(2):87-94.
11. Corbett B, Khan K, Czapansky-Beilman D, Brady N, Dropik P, Goldman DZ, et al. A double-blind, placebo-controlled cross-over study investigating the effect of porcine secretin in children with autism. Clin Pediatr (Phila) 2001; 40(6):327-31.
12. Lightdale JR, Hayer C, Duer A, Lind-White C, Jenkin S, Siegel B, Elliott GR, et al. Effects of intravenous secretin on language and behaviour of children with autism and gastrointestinal symtoms: a single-blinded, open-label pilot study. Pediatrics 2001; 108(5):E90.
13. Roberts W, Weaver L, Brian J, Bryson S, Emelianova S, Griffiths AM, et al. Repeated doses of porcine secretin in the treatment of autism: a randomised, placebo-controlled trial. Pediatrics 2001; 107(5):E71.
14. Carey T, Ratliff-Scaub K, Funk J, Weinle C, Myers Jenks J. Double-blind placebo-controlled trial of secretin: effects on aberrant behaviour in children with autism. J Autism Dev Disord 2002; 32(3):161-7.
15. Sponheim E, Oftedel G, Helverschou SB. Multiple doses of secretin in the treatment of autism: a controlled study. Acta Paediatr 2002; 91(5):540-5.
16. Bolman WM, Richmond JA. A double-blind, placebo-controlled, crossover pilot trial of low dose dimethyglycine in patients with autistic disorder. J Autism Dev Disord 1999; 29(3):191-4.
17. Rimland B, Callaway E, Dreyfus P. The effect of high doses of vitamin B6 on autistic children:a double-blind crossover study. Am J Psychiatry, 1987; 135(4):472-5
18. Findling RL, Maxwell K, Scotese-Wojtila L, Huang J, Yamashita T, Wiznitzer M. High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study. J Autism Dev Disord 1997; 28(6):581-2.
19. Pfeiffer SI, Norton J, Nelson L, Shott S. Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes. J Autism Dev Disord 1995; 25(5):481-93.
20. Lelord G, Muh JP, Barthelemy C, Garreau B, Callaway E. Effects of pyridoxine and magnesium on autistic symptoms - initial observations. J Autism Dev Disord. 1981; 11(2):219-30
21. McCarthy DM, Coleman M. Response of intestinal mucosa to gluten challenge in autistic subjects. Lancet 1979; 2(8184):877-8.
22. Knivsberg AM, Reichelt KL, Hoien T, Nodland M. A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci 2002; 5(4):251-61.
23. American Academy of Pediatrics. Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000; 105:1158-70.
24. Wolraich ML, Hannah JN, Baumgaertel A, Feurer ID: Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr 1998; 19:162-8.
25. American Psychiatric Association. Diagnostic Statistical Manual-IV, Washington DC, 2000.
26. Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, et al. Findings from the NIMH Multimodal treatment study of ADHD (MTA): Implications and Applications for Primary Care providers. Developmental and Behavioral Pediatrics 2001; 22(1):60-73.
27. Feingold BW. Why Your Child Is Hyperactive. New York, USA: Random House 1975.
28. Feingold H, Feingold B. The Feingold Cookbook for Hyperactive Children And Others With Problems Associated With Food Additives and Salicylates. New York, USA: Random House 1979.
29. Wender EH, Lipton MA. The National Advisory Committee Report on Hyperkinesis and Food Additives - Final Report to the Nutrition Foundation. Washington DC: The Nutrition Foundation, 1980.
30. Mattes JA, Gittelman R. Effects of artificial food colourings in children with hyperactive symptoms. A critical review and results of a controlled study. Arch Gen Psychiatry 1981; 38(6):714-8.
31. Lipton MA, Mayo JP. Diet and hyperkinesis - an update. J Am Diet Assoc 1983; 83(2):132-4.
32. Gross MD, Tofanelli RA, Butzius SM, Snodgreaa EW. The effects of diets rich in and free from additives on the behaviour of children with hyperkinctic and learning disorders. Journal of the American Academy of Child and Adolescent Psychiatry 1987; 26:53-5.
33. Rowe KS. Synthetic food colourings and 'hyperactivity": A double-blind crossover study. Aust Paediatric Journal 1988; 24:143-7.
34. Wolraich ML, Lindgren SD, Stumbo PJ, Stegink LD, Appelbaum MI, Kiritsy MC. Effects of diets high in sucrose or aspartame on the behaviour and cognitive performance of children. N Engl J Med 1994; 330(5):301-7.
35. Wolraich ML, Wilson DB, White JW. The effect of sugar on behaviour or cognition in children. A meta-analysis. JAMA 1995; 275(10):756-7.
36. Krummel DA, Seligson FH, Guthrie HA. Hyperactivity: is candy causal? Cri Rev Food Sci Nutr 1996; 36(1-2):31-47.